Status:
COMPLETED
The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to see how taking certain anti-HIV drugs affects the way the body metabolizes fat. This study will evaluate patients who are enrolled in CPCRA 058 (the FIRST \[Flexible In...
Detailed Description
Close to 3 years into widespread PI use, several toxicities, including metabolic alterations, are being reported increasingly in conjunction with the use of PI-containing regimens. Some of the manifes...
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Are enrolled in the FIRST study (CPCRA 058).
- Have written informed consent of parent or guardian if under the age of 18.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
June 1 2006
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT00001102
End Date
June 1 2006
Last Update
April 17 2014
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Consortium / UCSF
San Francisco, California, United States, 94110
2
Denver CPCRA / Denver Public Hlth
Denver, Colorado, United States, 802044507
3
Washington Reg AIDS Prog / Dept of Infect Dis
Washington D.C., District of Columbia, United States, 20422
4
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States, 303081962